Williams: Court of Chancery Finds Poison Pill Unenforceable -
In February, the Delaware Court of Chancery held that a shareholder rights plan (a "poison pill") adopted by The Williams Companies, Inc. at the onset of the...more
7/30/2021
/ Acquisition Agreements ,
Acquisitions ,
Activist Investors ,
Board of Directors ,
Breach of Contract ,
Buyers ,
Coronavirus/COVID-19 ,
Corporate Counsel ,
Domestic Dealmaking ,
Earn-Outs ,
Global Dealmaking ,
Material Adverse Effects ,
Mergers ,
Motion to Dismiss ,
Poison Pill ,
Private Equity Firms ,
Purchase Agreement ,
Sellers ,
Shareholders
We focus on two H2 2019 rulings that could affect M&A transactions in the future.
Genuine Parts: Acceptance of termination fee does not prevent further remedies -
In September 2019, the Delaware Chancery Court refused to...more
2/19/2020
/ Acquisitions ,
Appeals ,
Attorney-Client Privilege ,
Breach of Contract ,
Choice-of-Law ,
Contract Drafting ,
Contract Terms ,
Corporate Counsel ,
Corporate Restructuring ,
Domestic Dealmaking ,
Exclusive Remedy ,
Merger Agreements ,
Merger Remedies ,
Mergers ,
Motion to Dismiss ,
Privileged Communication ,
Reorganizations ,
Sellers ,
Termination Clauses ,
Termination Fees